Video: Anti-Aging Pill Sparks Debate

May 22, 2012

Brad Johnson of the Perelman School of Medicine shares his concerns about an anti-aging pill.

Article Source: NBC10 Philadelphia

Entitlement Reform for the Entitled

May 20, 2012

Ezekiel Emanuel of the Perelman School of Medicine and the Wharton School contributes his views about entitlement spending and reform.

Article Source:

New Study Finds Sleepwalking More Prevalent Than Previously Assumed

May 16, 2012

Philip Gehrman of the Perelman School of Medicine shares his thoughts on a new study about sleepwalking.

Article Source: Newsworks

Research Questions Efficacy of Boosting ‘Good’ Cholesterol

May 17, 2012

Ben Voight of the Perelman School of Medicine is mentioned as co-author of a study about HDL levels.

Article Source: Newsworks
facebook twitter google print email
Media Contact:Karen Kreeger | | 215-349-5658May 16, 2012

FDA-approved Drug Makes Established Cancer Vaccine Work Better, Penn Study Finds

A team from the Perelman School of Medicine and the Abramson Family Cancer Research Institute at the University of Pennsylvania found that the FDA-approved drug daclizumab improved the survival of breast cancer patients taking a cancer vaccine by 30 percent, compared to those patients not taking daclizumab. This proof-of-concept study is published this week in Science Translational Medicine.

FDA Panel Backs At-Home HIV Test That Analyzes Mouth Swab in 20 Minutes

May 16, 2012

Arthur Caplan of the Perelman School of Medicine comments on ethical concerns associated with at-home HIV testing kits.

Article Source: CBC News
facebook twitter google print email
Media Contact:Jessica Mikulski | | 215-349-8369May 17, 2012

Penn Medicine Research Challenges Concept That Raising HDL Helps Counter Heart-attack Risk

A new study published by researchers at the Perelman School of Medicine at the University of Pennsylvania, the Broad Institute, and Massachusetts General Hospital, challenges the conventional concept that raising a person's HDL levels (good cholesterol) will always help lower their risk of a heart attack.

facebook twitter google print email
Media Contact:Karen Kreeger | | 215-349-5658
Media Contact:Jessica Mikulski | | 215-349-8360May 9, 2012

Penn Med-led Cardiovascular Health Screening Technology Receives Development Funding From AHA

The American Heart Association (AHA) announced today that they have made their first investment through the Science & Technology Accelerator Program into CytoVas, LLC. The company was founded by Jonni S.

Media Contact:Evan Lerner | | 215-573-6604May 17, 2012

Penn Researchers Recognized for Improving Nanotech Design Principles

PHILADELPHIA — Targeted drug delivery is one of the more enticing applications of nanotechnology; by designing pharmaceuticals on an atomic scale, engineers hope to get them attacking diseases with newfound precision and efficiency.

A team of University of Pennsylvania researchers has recently been recognized by the National Science Foundation for the development of computer models that will be instrumental in improving these designs.

Malaria Drug May Be Useful in Fight Against Cancer

May 13, 2012

Ravi Amaravadi of the Perelman School of Medicine and Jeffrey Winkler of the School of Arts and Sciences comment on a malaria drug that might have the ability to fight cancer.

Article Source: CBS Local